The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer's Disease

Bone, the major structural scaffold of the human body, has recently been demonstrated to interact with several other organ systems through the actions of bone-derived cells and bone-derived cell secretory proteins. Interestingly, the brain is one organ that appears to fall into this interconnected n...

Full description

Saved in:
Bibliographic Details
Published inJournal of Alzheimer's disease Vol. 69; no. 1; p. 59
Main Authors Yuan, Jun, Meloni, Bruno P, Shi, Tianxing, Bonser, Anne, Papadimitriou, John M, Mastaglia, Frank L, Zhang, Changqing, Zheng, Minghao, Gao, Junjie
Format Journal Article
LanguageEnglish
Published Netherlands 01.01.2019
Subjects
osteocalcin
bone
Alzheimer’s disease
microglia
mesenchymal stem cells
Online AccessGet more information

Cover

More Information
Summary:Bone, the major structural scaffold of the human body, has recently been demonstrated to interact with several other organ systems through the actions of bone-derived cells and bone-derived cell secretory proteins. Interestingly, the brain is one organ that appears to fall into this interconnected network. Furthermore, the fact that osteoporosis and Alzheimer's disease are two common age-related disorders raises the possibility that these two organ systems are interconnected in terms of disease pathogenesis. This review focuses on the latest evidence demonstrating the impact of bone-derived cells and bone-derived proteins on the central nervous system, and on how this may be relevant in the progression of Alzheimer's disease and for the identification of novel therapeutic approaches to treat this neurodegenerative disorder.
ISSN:1875-8908
DOI:10.3233/JAD-181249